Diagnostic Value of Cystatin C and Uric Acid for Early Renal Impairment in Kazakh Patients with H-type Hypertension

doi:10.12114/j.issn.1007-9572.2018.00.035

Abstract

Abstract: Background　Cystatin C （CysC） and uric acid （UA） are closely related to renal impairment in patients with hypertension，and have become a hot research topic in recent years.Objective　To investigate the value of CysC and UA in diagnosis of early renal impairment in Kazakh patients with H-type hypertension.Methods　A total of 318 Kazakh patients with H-type hypertension who participated in the epidemiological investigation in Xinjiang between May 2014 and August 2015 were selected randomly.According to their eGFR levels，the patients were divided into a renal function impairment group〔n=174，eGFR<90 ml?min-1?（1.73 m2）-1〕 and a normal renal function group 〔n=144，eGFR≥90 ml?min-1?（1.73 m2）-1〕.Baseline data were compared between the two groups，and the correlations among CysC，UA and eGFR were analyzed.Factors influencing early renal impairment in Kazakh patients with H-type hypertension，as well as the value of CysC and UA in diagnosis of the condition，were investigated.Results　The indicators age，systolic blood pressure（SBP），diastolic blood pressure（DBP），triglyceride（TG），low density lipoprotein cholesterol（LDL-C），blood urea nitrogen（BUN），creatinine（Cr），homocysteine（Hcy），CysC and UA were higher in the renal function impairment group than in the normal renal function group（P<0.05）.CysC and UA were negatively correlated with eGFR（r=-0.791 and -0.671，P<0.05）.Multivariate Logistic regression showed that LDL-C，CysC，and UA were influencing factors for early renal impairment in Kazakh patients with H-type hypertension（P<0.05）.The areas under the ROC curve（AUC） of CysC and UA in the diagnosis of early renal impairment in these patients were 0.967〔95%CI（0.946，0.989）〕 and 0.875〔95%CI（0.837，0.913）〕.Conclusion　CysC and UA are correlated with early renal impairment in Kazakh patients with H-type hypertension and are a favorable indicator for the diagnosis of early renal impairment.

Key words: Hypertension, Kidney injury, Kazakh, Cystatin C, Uric acid, Glomerular filtration rate

摘要： 背景　胱抑素C（CysC）、尿酸（UA）与高血压患者的肾损害密切相关，已成为近年来研究的热点。目的　探讨CysC、UA对哈萨克族H型高血压患者初期肾损害的诊断价值。方法　随机抽取2014年5月—2015年8月参与新疆地区流行病学调查的哈萨克族H型高血压患者318例为研究对象，依据估算肾小球滤过率（eGFR）将患者分为肾损害组〔n=174，eGFR<90 ml?min-1?（1.73 m2）-1〕、肾功能正常组〔n=144，eGFR≥90 ml?min-1?（1.73 m2）-1〕。比较两组患者的基线资料；分析CysC、UA与eGFR的相关性，哈萨克族H型高血压患者初期肾损害的影响因素以及CysC、UA诊断哈萨克族H型高血压患者初期肾损害的价值。结果　肾损害组患者年龄、收缩压（SBP）、舒张压（DBP）、三酰甘油（TG）、低密度脂蛋白胆固醇（LDL-C）、血尿素氮（BUN）、肌酐（Cr）、同型半胱氨酸（Hcy）、CysC、UA高于肾功能正常组（P<0.05）。CysC、UA与eGFR呈负相关（r值分别为-0.791、-0.671，P<0.05）。多因素Logistic回归分析结果显示，LDL-C、CysC、UA是哈萨克族H型高血压患者初期肾损害的影响因素（P<0.05）。CysC、UA诊断哈萨克族H型高血压患者初期肾损害的受试者工作特征曲线（ROC）曲线下面积（AUC）分别为0.967〔95%CI（0.946，0.989）〕、0.875〔95%CI（0.837，0.913）〕。结论　哈萨克H 型高血压患者 CysC、UA与初期肾损害有相关性，并对其有一定的诊断价值，可作为诊断初期肾损害的重要指标。

关键词: 高血压, 肾损害, 哈萨克族, 胱抑素C, 尿酸, 肾小球滤过率

LI Ruru,CHEN Shaoze,LIU Jingjing, et al. Diagnostic Value of Cystatin C and Uric Acid for Early Renal Impairment in Kazakh Patients with H-type Hypertension[J]. Chinese General Practice, 2019, 22(6): 664-667. DOI: 10.12114/j.issn.1007-9572.2018.00.035.
李茹茹,陈少泽,刘晶晶等. 胱抑素C和尿酸对哈萨克族H型高血压患者初期肾损害的诊断价值研究[J]. 中国全科医学, 2019, 22(6): 664-667. DOI: 10.12114/j.issn.1007-9572.2018.00.035.

References

［1］胡大一，徐西平.有效控制“H型”高血压——预防卒中的新思路［J］．中华内科杂志，2008，47（12）：976-977．DOI：10.3321/j.issn：0578-1426.2008.12.005.
［2］高向阳，杨春显，周紫燕，等．胱抑素C在原发性高血压早期肾损害诊断中的临床意义［J］．中国卫生检验杂志，2015，25（23）：4090-4091，4094.
GAO X Y，YANG C X，ZHOU Z Y，et al．The clinical significance of serum cystatin C in the diagnosis of patients with essential hypertension early renal damage［J］．Chinese Journal of Health Laboratory Technology，2015，25（23）：4090-4091，4094.
［3］莫新玲，杨锡恒，谢婷，等．H型高血压患者Hcy、Cyst-C、UACR与早期肾损害的关系［J］．广东医学，2015，36（23）：3623-3626.
MO X L，YANG X H，XIE T，et al．Relationship of homocysteine，cystain C，urinary albumin to creatinine ratio with early renal injury in H-type hypertension patients［J］．Guangdong Medical Journal，2015，36（23）：3623-3626.
［4］GUO S，PANG H，GUO H，et al．Ethnic differences in the prevalence of high homocysteine levels among low-income rural Kazakh and Uyghur adults in far western China and its implications for preventive public health［J］．Int J Environ Res Public Health，2015，12（5）：5373-5385．DOI：10.3390/ijerph120505373.
［5］中国高血压防治指南修订委员会.中国高血压防治指南2010［J］．中华高血压杂志，2011，19（8）：701-706.
Writing Group of 2010 Chinese Guidelines for the Management of Hypertension.2010 Chinese guidelines for the management of hypertension［J］．Chin J Hypertens，2011，19（8）：701-706.
［6］全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估［J］．中华肾脏病杂志，2006，22（10）：589-595．DOI：10.3760/j.issn：1001-7097.2006.10.002.
Chinese eGFR Investigation Collaboration.Modification and evaluation of MDRD estimating equation for Chinese patients with chronic kidney disease［J］．Chinese Journal of Nephrology，2006，22（10）：589-595．DOI：10.3760/j.issn：1001-7097.2006.10.002.
［7］梁海峰，杨明，刘瑜，等．血浆同型半胱氨酸水平对非ST段抬高急性冠脉综合征患者围术期心肌梗死及预后的影响研究［J］．中国全科医学，2017，20（7）：823-827．DOI：10.3969/j.issn.1007-9572.2017.07.013.
LIANG H F，YANG M，LIU Y，et al．Effect of plasma homocysteine level on the myocardial infarction during perioperative period and prognosis of patients with non-ST segment elevation acute coronary syndrome［J］．Chinese General Practice，2017，20（7）：823-827．DOI：10.3969/j.issn.1007-9572.2017.07.013.
［8］ILHAN N，KUCUKSU M，KAMAN D，et al．The 677 C/T MTHFR polymorphism is associated with essential hypertension，coronary artery disease，and higher homocysteine levels［J］．Arch Med Res，2008，39（1）：125-130．DOI：10.1016/j.arcmed.2007.07.009.
［9］MALDONADO C，SONI C V，TODNEM N D，et al．Hyperhomocysteinemia and sudden cardiac death：potential arrhythmogenic mechanisms［J］．Curr Vasc Pharmacol，2010，8（1）：64-74．
［10］李瑞瑞，庞晓．血同型半胱氨酸与高血压患者脑出血的关系［J］．中华高血压杂志，2014，22（2）：181-183．
［11］左希宏，张会珍，王景俊.H型高血压与早期肾损害的相关性分析［J］．中华临床医师杂志（电子版），2015，9（7）：27-29．DOI：10.3877/cma.j.issn.1674-0785.2015.07.008.
ZUO X H，ZHANG H Z，WANG J J.Correlation analysis of H type hypertension and the early renal damage［J］．Chinese Journal of Clinicians （Electronic Edition），2015，9（7）：27-29．DOI：10.3877/cma.j.issn.1674-0785.2015.07.008.
［12］李小雷，王忠，陈少泽，等．哈萨克族H型高血压患者血清同型半胱氨酸水平与临床特征的关系［J］．山东医药，2016，56（5）：13-15．DOI：10.3969/j.issn.1002-266X.2016.05.005.
LI X L，WANG Z，CHEN S Z，et al．Serum homocysteine level in H-type hypertensive patients of Kazakh and its relationships with clinical features［J］．Shandong Pharmaceutical，2016，56（5）：13-15．DOI：10.3969/j.issn.1002-266X.2016.05.005.
［13］魏丽丽，徐新娟，珠勒皮亚?司马义，等．血清胱抑素C在高血压患者肾功能评价中的应用［J］．中华高血压杂志，2014，22（1）：79-81．DOI：10.16439/j.cnki.1673-7245.
2014.01.019.
［14］ORTUNO-ANDERIZ F，CABELLO-CLOTET N，VIDART-SIMON N，et al．Cystatin C as an early marker of acute kidney injury in septic shock［J］．Rev Clin Esp，2015，215（2）：83-90．DOI：10.1016/j.rce.2014.09.010.
［15］黄国秀，余文珊.2型糖尿病患者动态脉压与胱抑素C及尿微量蛋白的相关性［J］．广东医学，2011，32（3）：367-368．DOI：10.3969/j.issn.1001-9448.2011.03.040.
［16］刘华，林娜.高尿酸血症患者早期肾损害特点［J］．中国老年学杂志，2015，35（12）：3312-3313．DOI：10.3969/j.issn.1005-9202.2015.12.057.
［17］寇惠娟，韩振华，董新，等．高血压高尿酸血症患者与肾损害的关系［J］．陕西医学杂志，2016，45（4）：415-416．DOI：10.3969/j.issn.1000-7377.2016.04.015.
［18］KANG D H，NAKAGAWA T，FENG L，et al．A role for uric acid in the progression of renal disease［J］．J Am Soc Nephrol，2002，13（12）：2888-2897.
［19］ANAND N N，PADMA V，PRASAD A，et al．Serum uric acid in new and recent onset primary hypertension［J］．J Pharm Bioallied Sci，2015，7（Suppl 1）：S4-8．DOI：10.4103/0975-7406.155763.
［20］NAKANISHI N，OKAMOTO M，YOSHIDA H，et al．Serum uric acid and risk for development of hypertension and impaired fasting glucose or type Ⅱ diabetes in Japanese male office workers［J］．Eur J Epidemiol，2003，18（6）：523-530.

[1]	LIN Zehua, ZHANG Lan, DAI Shanshan, WEI Yuanyuan, LI Xingli, MA Yingchun. Evaluation and Comparison of Multidimensional Functional Disability in Geriatric Comorbidities and Comorbid Acute Kidney Injury [J]. Chinese General Practice, 2026, 29(32): 4777-4782.
[2]	YANG Caiyi, HU Xiaohai, ZHU Hongjun, XU Yifan. Therapeutic Effect of Chaigu Decoction Combined with Western Medicine on Hypertension with Liver Depression and Blood Deficiency Pattern and Its Serum Metabolomics Analysis [J]. Chinese General Practice, 2026, 29(31): 4589-4599.
[3]	WANG Dunjian, CHEN Yonggang, HU Bing, ZHAO Hengyi, YANG Qing. Application of Home-based Medication Therapy Management in Contracted Patients with Diabetes and Hypertension: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(29): 4226-4231.
[4]	WANG Lin, CAO Chenchen, HUANG Yichong, LIU Jing. Development of Preference Attributes and Levels of Family Doctor Contract Services for Patients with Comorbidity of Hypertension and Type 2 Diabetes Mellitus Based on Discrete Choice Experiments [J]. Chinese General Practice, 2026, 29(29): 4232-4240.
[5]	WANG Lei, DU Zhicai, YU Haiyang, ZHAO Zeyu. The Value of Platelet-to-lymphocyte Ratio and Uric Acid in Early Differentiation of Spinal Tuberculosis from Brucellar Spondylitis [J]. Chinese General Practice, 2026, 29(29): 4265-4271.
[6]	FU Xiaoya, YANG Fei, GU Keyi, GU Handong, WANG Weiqiang. Correlation between Relative Fat Mass Index and Decreased Glomerular Filtration Rate in Patients with Cardiometabolic Comorbidities [J]. Chinese General Practice, 2026, 29(28): 4187-4192.
[7]	LU Hongrun, ZHANG Rui, ZHAO Yu, LI Jiazhen, WANG Weiqiang. Association of Cardiometabolic Comorbidity with Estimated Glomerular Filtration Rate [J]. Chinese General Practice, 2026, 29(28): 4179-4186.
[8]	YANG Rui, LIAO Xiaoyang, HUANG Chuanying, YANG Ziyu, SHEN Can, JIA Yu, LIU Lidi, YANG Rong. Interpretation of the 2024 British and Irish Hypertension Society Position Statement: Investigation and Management of Hypertension in Young People [J]. Chinese General Practice, 2026, 29(26): 3726-3732.
[9]	LI Xiaoxue, YIN Lihua, SU Xu, ZHANG Fuyan, ZHAN Qingqing, AN Qinyu, WANG Huiqun, LIU Tao, TAN Shisheng. Association between Dietary Quality and Risk of Hypertension: a Study Based on the 2022 Version of the Chinese Dietary Balance Index [J]. Chinese General Practice, 2026, 29(25): 3631-3639.
[10]	XUE Cuirong, WEI Wei, WU Renyuan, XUE Yaqin, XU Huijiang, LYU Weijiang, JIANG Dandan. Prevalence and Management Status of Chronic Kidney Disease in Hypertensive and Type 2 Diabetic Populations: a Community-based Cross-sectional Study [J]. Chinese General Practice, 2026, 29(25): 3650-3654.
[11]	SUN Qinyu, DENG Yifan, YU Jiling, CAO Gan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Study on the Predictive Value of Cumulative LDL-C Exposure and Uric Acid/HDL-C Ratio in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(24): 3447-3453.
[12]	ZHANG Wenzheng, ZHANG Hongling. Association between Cardiometabolic Index and Hypertension in Elderly Patients with Metabolic Associated Fatty Liver Disease in the Community Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(23): 3261-3267.
[13]	ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia. Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension [J]. Chinese General Practice, 2026, 29(21): 2975-2981.
[14]	FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063.
[15]	REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845.